2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | - | - | - | 50.561 | 152.246 | 147.190 |
Total Income - EUR | - | - | - | - | - | - | - | 50.562 | 152.248 | 147.278 |
Total Expenses - EUR | - | - | - | - | - | - | - | 39.433 | 107.200 | 93.287 |
Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 11.129 | 45.048 | 53.991 |
Net Profit/Loss - EUR | - | - | - | - | - | - | - | 10.623 | 43.525 | 52.518 |
Employees | - | - | - | - | - | - | - | 11 | 12 | 11 |
Check the financial reports for the company - Dr Bodnar. Regenerol-Ghergulescu S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | - | - | - | 0 | 750 | 748 |
Current Assets | - | - | - | - | - | - | - | 15.826 | 50.660 | 17.925 |
Inventories | - | - | - | - | - | - | - | 4.525 | 299 | 298 |
Receivables | - | - | - | - | - | - | - | 6.699 | 252 | 9.058 |
Cash | - | - | - | - | - | - | - | 4.602 | 50.110 | 8.570 |
Shareholders Funds | - | - | - | - | - | - | - | 10.663 | 993 | 12.752 |
Social Capital | - | - | - | - | - | - | - | 40 | 41 | 40 |
Debts | - | - | - | - | - | - | - | 5.162 | 50.418 | 5.921 |
Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Dr Bodnar. Regenerol-Ghergulescu S.r.l.